Article
Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
16 Apr 2019
Abstract excerpt
BACKGROUND: It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported member of B7 family, is uniquely expressed in humans but not in mice, and it plays an important role in the functional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
